Journal of Child and Adolescent Psychopharmacology

J Child Adolesc Psychopharmacol

1044-5463

1557-8992

Therapeutic Area

Anxiety, Behavioral Health Services, Bipolar Disorders, Health Economics/Outcomes Research, Health Policy, Neurology, Neuroscience, Pediatrics, Pharmacology, Psychiatry, Psychology, Substance Abuse

Neurologists, Neuroscientists, Pediatricians, Pharmacologists, Psychiatrists, Psychologists

Journal of Child and Adolescent Psychopharmacology (JCAP) is the premier peer-reviewed journal covering the clinical aspects of treating this patient population with psychotropic medications including side effects and interactions, standard doses, and research on new and existing medications. The Journal includes information on related areas of medical sciences such as advances in developmental pharmacokinetics, developmental neuroscience, metabolism, nutrition, molecular genetics, and more. Coverage includes: New drugs and treatment strategies including the use of psycho-stimulants, selective serotonin reuptake inhibitors, mood stabilizers, and atypical antipsychotics; New developments in the diagnosis and treatment of ADHD, anxiety disorders, schizophrenia, autism spectrum disorders, bipolar disorder, eating disorders, along with other disorders; Reports of common and rare Treatment Emergent Adverse Events (TEAEs) including: hyperprolactinemia, galactorrhea, weight gain/loss, metabolic syndrome, dyslipidemia, switching phenomena, sudden death, and the potential increase of suicide; Outcome Research

No associations affiliated with this journal

Mary Ann Liebert, Inc.

Impact Factor JCR Categories/Rank Circulation Electronic Circulation Submission to Acceptance Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines